All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
APREA THERAPEUTICS, INC. Last Reported: 1/31/2024 Stock Symbol: APRE

Business Address

3805 OLD EASTON ROAD

DOYLESTOWN , PA US 18902

Mailing Address

3805 OLD EASTON ROAD

DOYLESTOWN , PA US 18902
Phone Number: 617-463-9385 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 12/31/2017 12/31/2016
Cash and Cash Equivalents $25,353,513.00 $27,685,131.00 $28,786,647.00 $33,112,601.00 $39,062,415.00 $47,651,774.00 $53,076,052.00 $61,428,404.00 $69,800,000.00 $89,017,686.00 $101,146,633.00 $112,861,504.00 $122,513,357.00 $130,088,869.00 $52,334,102.00 -- -- $65,675,931.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $286,263.00 $953,670.00 $1,366,859.00 $361,178.00 $1,400,837.00 $2,393,096.00 $3,508,358.00 $750,929.00 $1,494,453.00 $3,399,019.00 $1,257,077.00 $1,475,223.00 $2,090,941.00 $2,955,878.00 $339,814.00 -- -- $322,146.00 -- -- -- --
Total Current Assets $25,639,776.00 $28,638,801.00 $30,153,506.00 $33,473,779.00 $40,463,252.00 $50,044,870.00 $56,584,410.00 $62,179,333.00 $71,298,298.00 $92,416,705.00 $102,403,710.00 $114,336,727.00 $124,604,298.00 $133,044,747.00 $56,744,606.00 -- -- $65,998,077.00 -- -- -- --
Property Plant and Equipement $86,198.00 $1,687.00 $2,321.00 $12,237.00 $20,258.00 $20,587.00 $23,870.00 $27,318.00 $30,955.00 $38,515.00 $40,696.00 $43,906.00 $45,934.00 $41,639.00 $31,032.00 -- -- $24,450.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- $29,351.00 $29,359.00 $29,369.00 $29,372.00 $29,375.00 $29,379.00 $29,383.00 $29,372.00 $29,368.00 $29,360.00 $107.00 $102.00 -- -- $111.00 -- -- -- --
Total Assets $25,766,423.00 $28,680,668.00 $30,155,827.00 $33,621,904.00 $40,683,836.00 $50,337,009.00 $56,823,463.00 $62,484,860.00 $71,549,730.00 $92,805,219.00 $102,834,388.00 $114,818,795.00 $125,125,130.00 $133,607,885.00 $57,336,058.00 -- -- $66,022,638.00 -- -- -- --
Accounts Payable $862,552.00 $1,131,197.00 $842,754.00 $1,136,064.00 $3,989,794.00 $1,988,007.00 $1,773,032.00 $2,548,388.00 $2,361,318.00 $4,503,619.00 $4,349,977.00 $5,443,126.00 $3,006,688.00 $2,176,852.00 $3,510,105.00 -- -- $1,739,337.00 -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities -- $3,950,821.00 $3,201,086.00 $3,998,139.00 $7,684,197.00 $6,748,183.00 $7,316,499.00 $9,069,589.00 $10,598,061.00 $15,410,012.00 $13,811,449.00 $14,698,439.00 $11,771,516.00 $9,364,355.00 $9,942,725.00 -- -- $4,868,109.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-10,635,874.00 $-10,634,872.00 $-10,623,408.00 $-10,240,645.00 $-10,266,806.00 $-10,424,461.00 $-10,358,956.00 $-10,454,699.00 $-10,247,091.00 $-10,037,261.00 $-12,370,630.00 $-12,201,648.00 $-13,958,431.00 $-11,533,778.00 $-13,688,166.00 -- -- $-8,761,325.00 -- -- -- --
Accumulated Deficit $-304,639,907.00 $-301,435,392.00 $-293,796,405.00 $-291,354,263.00 $-287,329,545.00 $-189,071,071.00 $-181,134,378.00 $-173,379,194.00 $-163,926,843.00 $-144,007,075.00 $-128,614,529.00 $-116,296,447.00 $-99,928,520.00 $-90,528,263.00 $-77,455,525.00 -- -- $-62,468,456.00 -- -- -- --
Total Stockholders' Equity $20,289,298.00 $23,418,784.00 $25,643,678.00 $26,625,228.00 $-35,777,829.00 $43,588,826.00 $49,506,964.00 $53,415,271.00 $60,951,669.00 $77,395,207.00 $89,022,939.00 $100,120,356.00 $113,353,614.00 $124,243,530.00 $-70,795,660.00 $-61,852,392.00 $-56,821,415.00 $-51,436,102.00 $-47,473,143.00 $-44,480,472.00 $-35,765,195.00 $-21,465,545.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $25,766,423.00 $28,680,668.00 $30,155,827.00 $33,621,904.00 $40,683,836.00 $50,337,009.00 $56,823,463.00 $62,484,860.00 $71,549,730.00 $92,805,219.00 $102,834,388.00 $114,818,795.00 $125,125,130.00 $133,607,885.00 $57,336,058.00 -- -- $66,022,638.00 -- -- -- --

Statement of Operations

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 12/31/2017 12/31/2016
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development -- -- -- -- -- $4,089,577.00 $23,895,875.00 $19,433,721.00 $13,418,105.00 $37,879,325.00 $28,551,246.00 $10,694,029.00 $9,096,122.00 $20,950,672.00 $12,908,679.00 $4,319,826.00 $3,678,444.00 $14,194,732.00 $9,799,811.00 -- $13,392,631.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $3,842,318.00 $3,901,369.00 $113,392,228.00 $4,200,194.00 $98,465,531.00 $8,074,875.00 $37,446,353.00 $29,617,674.00 $20,187,263.00 $52,811,212.00 $38,587,810.00 $14,480,915.00 $11,872,590.00 $29,544,298.00 $17,564,540.00 $5,938,415.00 $4,407,770.00 $16,489,403.00 $11,590,033.00 -- $15,852,375.00 --
Loss from Operations $-11,797,034.00 $-3,651,681.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-3.03 $-2.18 $-67.99 $-0.12 $-4.77 $-0.36 $-1.74 $-1.39 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 3,735,176 3,731,571 1,657,055 34,655,750 22,283,783 21,901,531 21,286,547 21,201,910 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.85 $-0.87 $-68.16 $-0.12 $-4.77 $-0.36 $-1.74 $-1.39 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 3,576,268 3,731,571 1,657,055 26,453,091 22,661,835 21,901,531 21,286,547 21,201,910 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 -- -- -- -- -- -- -- --
Common Stock Shares Outstanding 3,736,673 3,731,571 2,655,269 52,237,885 23,401,846 21,974,302 21,859,413 21,360,140 21,186,827 21,186,827 21,186,827 21,186,827 21,054,872 21,022,752 1,181,733 -- -- 1,155,366 -- -- -- --
Common Stock Value $3,736.00 $3,731.00 $2,655.00 $52,237.00 $23,401.00 $21,974.00 $21,859.00 $21,360.00 $21,187.00 $21,187.00 $21,187.00 $21,187.00 $21,055.00 $21,023.00 $1,182.00 -- -- $127,091.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.11 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 40,000,000 40,000,000 40,000,000 40,000,000 40,000,000 40,000,000 40,000,000 40,000,000 40,000,000 40,000,000 40,000,000 40,000,000 40,000,000 -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com